| 47.79 Delayed Data As of 4:00pm ET |  -0.42 / -0.87%Today’s Change | 44.30 Today|||52-Week Range 63.69 | -8.06% Year-to-Date |
| Previous close | 48.21 |
| Today’s open | 48.28 |
| Day’s range | 47.71 - 48.68 |
| Volume | 11,523,657 |
| Average volume (3 months) | 16,524,106 |
| Market cap | -- |
| Earnings growth (last year) | +393.92% |
| Earnings growth (this year) | +5.27% |
| Earnings growth (next 5 years) | +5.50% |
| Revenue growth (last year) | +8.59% |
| P/E ratio | 15.2 |
| Price/Sales | 3.77 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CELGCelgene | -0.15 | -0.15% |
| NVONovo Nordisk | +1.18 | +2.31% |
| GSKGlaxoSmithKline | +0.29 | +0.73% |
| TAKTakeda Pharmaceutica... | +0.15 | +0.88% |
| Next reporting date | July 25, 2019 |
| EPS forecast (this quarter) | $1.05 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.9B |
| Net profit margin | 21.81% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Giovanni Caforio |
CFO, EVP & Head-Global Business Operations Charles A. Bancroft |
Corporate headquarters New York, New York |
